1 ( Translation ) Ref. NEP146-2017 October 25, 2017 Subject : Resolutions of the Board of Directors approving the capital decrease, the capital increase, the allotment of newly issued ordinary shares
% - - Other income 4,552 13,328 -66% 4,187 5,055 -17% Total Revenues 498,549 853,833 -42% 387,061 325,824 19% Profit (Loss) before income tax (25,492) 200,062 -113% 25,757 (7,853) -428% Margin -5% 38% 7% -2
-102% Margin -1% -15% 44% Profit / (Loss) for the period (47,544) (132,736) 64% 191,233 -125% Margin -10% -26% 36% Portion of the Companies’ shareholders (6,923) (60,913) 89% 101,512 -107% Margin -1% -12
repayment of short- term borrowings from financial institutions by using money gained from trading of its ordinary shares in the MAI stock exchange. • Other current assets decreased by Baht 35.06 million
115.40% Gross profit margin 61.51% 59.98% 1.53% Net profit margin 45.50% 36.59% 8.91% บริษัท ดโีอด ีไบโอเทค จ ำกดั (มหำชน) 111 หมู่ที่ 2 ต ำบลท่ำจีน อ ำเภอเมืองสมุทรสำคร จังหวดัสมุทรสำคร 74000 111 Moo 2
of 200 million baht within the 2nd quarter of 2019, by issuing 2 million ordinary shares at par value of 100 baht. The company holds 62,500 ordinary shares of All S or current proportion of 6.25
margin ratio as mentioned above. However, the net profit attributable to the Company increased by 4% yoy because more profit contributed from subsidiary following the acquisition of shares to 98.31% from
Total Shareholders ' Equity -42.22 -26.39 -15.83 59.98 Basic Loss Per Share (Baht) -0.02 -0.09 Gross Margin 3.80% -11.00% Net Profit Margin -52.16% -42.47% Debt to Equity Ratio (Time) -9.36 -16.47 Total
1,403.07 13% Cost of hospital operations 276.11 258.34 7% 1,101.98 985.67 12% Gross margin 117.88 108.76 8% 485.45 417.39 16% % Gross margin 30% 30% 0% 31% 30% 1% Administrative expenses 41.54 40.51 3